• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Therapeutic drug monitoring for immune mediated inflammatory diseases.

作者信息

Chanchlani Neil, Yiu Zenas Z N, Stamp Lisa K, Day Andrew S

机构信息

Bristol Royal Hospital for Children, Bristol, UK.

Division of Musculoskeletal and Dermatological Sciences, School of Biological Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK.

出版信息

BMJ Med. 2024 Oct 28;3(1):e001130. doi: 10.1136/bmjmed-2024-001130. eCollection 2024.

DOI:10.1136/bmjmed-2024-001130
PMID:39574418
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11579535/
Abstract
摘要

相似文献

1
Therapeutic drug monitoring for immune mediated inflammatory diseases.免疫介导的炎症性疾病的治疗药物监测
BMJ Med. 2024 Oct 28;3(1):e001130. doi: 10.1136/bmjmed-2024-001130. eCollection 2024.
2
Effectiveness of interdisciplinary combined dermatology-gastroenterology-rheumatology clinical care compared to usual care in patients with immune-mediated inflammatory diseases: a parallel group, non-blinded, pragmatic randomised trial.跨学科联合皮肤科-胃肠病学-风湿病学临床护理与常规护理在免疫介导的炎症性疾病患者中的疗效比较：一项平行组、非盲、实用随机试验。
BMJ Open. 2021 Apr 28;11(4):e041871. doi: 10.1136/bmjopen-2020-041871.
3
Lines of therapy with biological drugs in dermatology, gastroenterology, and rheumatology practices in Germany
.德国皮肤科、胃肠病学和风湿病学实践中生物药物的治疗线
Int J Clin Pharmacol Ther. 2019 Apr;57(4):182-187. doi: 10.5414/CP203371.
4
[National consensus statement by the Austrian Societies for Rheumatology, Pulmonology, Infectiology, Dermatology and Gastroenterology regarding the management of latent tuberculosis and the associated utilization of biologic and targeted synthetic DMARDS (disease modifying antirheumatic drugs)].[奥地利风湿病学会、肺病学会、传染病学会、皮肤病学会和胃肠病学会关于潜伏性结核病管理及生物和靶向合成改善病情抗风湿药（DMARDs）相关应用的全国共识声明]
Z Rheumatol. 2023 Mar;82(2):163-174. doi: 10.1007/s00393-022-01274-6. Epub 2022 Nov 7.
5
National consensus statement by the Austrian Societies for Rheumatology, Pulmonology, Infectiology, Dermatology and Gastroenterology regarding the management of latent tuberculosis and the associated utilization of biologic and targeted synthetic disease modifying antirheumatic drugs (DMARDs).奥地利风湿病学会、肺病学会、传染病学会、皮肤病学会和胃肠病学会关于潜伏性结核病管理以及生物制剂和靶向合成的疾病修饰抗风湿药物（DMARDs）相关使用的国家共识声明。
Wien Klin Wochenschr. 2022 Nov;134(21-22):751-765. doi: 10.1007/s00508-022-02062-7. Epub 2022 Aug 29.
6
Immune-mediated inflammatory diseases: progress in molecular pathogenesis and therapeutic strategies.免疫介导的炎症性疾病：分子发病机制和治疗策略的进展。
Expert Rev Clin Immunol. 2013 Apr;9(4):297-9. doi: 10.1586/eci.13.10.
7
Launch and preliminary analysis of Hospital de La Princesa's inter-specialists biological therapies unit.
Reumatol Clin (Engl Ed). 2019 Mar-Apr;15(2):63-68. doi: 10.1016/j.reuma.2018.11.008. Epub 2019 Jan 26.
8
Practical recommendations for the use of therapeutic drug monitoring of biopharmaceuticals in inflammatory diseases.炎症性疾病中生物制药治疗药物监测应用的实用建议。
Clin Pharmacol. 2017 Oct 3;9:101-111. doi: 10.2147/CPAA.S138414. eCollection 2017.
9
A multidisciplinary dermatology-gastroenterology-rheumatology (DER.RE.GA) unit for the care of patients with immune-mediated inflammatory diseases: analysis of the first 5 years from the dermatologist's perspective.一个用于诊治免疫介导性炎症疾病患者的皮肤科、胃肠病科、风湿病科多学科联合（DER.RE.GA）科室：从皮肤科医生角度对前5年的分析
Front Med (Lausanne). 2023 Nov 30;10:1290018. doi: 10.3389/fmed.2023.1290018. eCollection 2023.
10
Clinical consequences of infliximab immunogenicity and the effect of proactive therapeutic drug monitoring: exploratory analyses of the randomised, controlled NOR-DRUM trials.英夫利昔单抗免疫原性的临床后果及主动治疗药物监测的影响：对随机对照 NOR-DRUM 试验的探索性分析。
Lancet Rheumatol. 2024 Apr;6(4):e226-e236. doi: 10.1016/S2665-9913(23)00341-7. Epub 2024 Feb 22.

本文引用的文献

1
Proactive therapeutic drug monitoring of biologic drugs in adult patients with inflammatory bowel disease, inflammatory arthritis, or psoriasis: a clinical practice guideline.生物药物在炎症性肠病、炎症性关节炎或银屑病成人患者中的主动治疗药物监测：临床实践指南。
BMJ. 2024 Oct 28;387:e079830. doi: 10.1136/bmj-2024-079830.
2
Mechanisms and management of loss of response to anti-TNF therapy for patients with Crohn's disease: 3-year data from the prospective, multicentre PANTS cohort study.抗 TNF 治疗克罗恩病患者应答丧失的机制和管理：前瞻性、多中心 PANTS 队列研究的 3 年数据。
Lancet Gastroenterol Hepatol. 2024 Jun;9(6):521-538. doi: 10.1016/S2468-1253(24)00044-X. Epub 2024 Apr 16.
3
Efficacy, safety, and cost-effectiveness of therapeutic drug monitoring (TDM) for TNF inhibitor therapy in rheumatic disease: A systematic review and meta-analysis.治疗药物监测（TDM）在风湿性疾病 TNF 抑制剂治疗中的疗效、安全性和成本效益：系统评价和荟萃分析。
Semin Arthritis Rheum. 2023 Dec;63:152302. doi: 10.1016/j.semarthrit.2023.152302. Epub 2023 Nov 4.
4
Global, regional, and national incidence of six major immune-mediated inflammatory diseases: findings from the global burden of disease study 2019.六种主要免疫介导性炎症疾病的全球、区域和国家发病率：全球疾病负担研究2019的结果
EClinicalMedicine. 2023 Sep 9;64:102193. doi: 10.1016/j.eclinm.2023.102193. eCollection 2023 Oct.
5
GRADE guidance 36: updates to GRADE's approach to addressing inconsistency.GRADE 指南 36：更新 GRADE 解决不一致性的方法。
J Clin Epidemiol. 2023 Jun;158:70-83. doi: 10.1016/j.jclinepi.2023.03.003. Epub 2023 Mar 9.
6
Meta-analysis: The efficacy of therapeutic drug monitoring of anti-TNF-therapy in inflammatory bowel disease.Meta 分析：抗 TNF 治疗炎症性肠病的治疗药物监测的疗效。
Aliment Pharmacol Ther. 2023 Jun;57(12):1362-1374. doi: 10.1111/apt.17313. Epub 2022 Dec 9.
7
Managing inadequate response to initial anti-TNF therapy in rheumatoid arthritis: optimising treatment outcomes.应对类风湿关节炎初始抗TNF治疗反应不足：优化治疗效果
Ther Adv Musculoskelet Dis. 2022 Aug 16;14:1759720X221114101. doi: 10.1177/1759720X221114101. eCollection 2022.
8
Proactive Therapeutic Drug Monitoring Versus Conventional Management for Inflammatory Bowel Diseases: A Systematic Review and Meta-Analysis.主动治疗药物监测与炎症性肠病的常规管理：系统评价和荟萃分析。
Gastroenterology. 2022 Oct;163(4):937-949.e2. doi: 10.1053/j.gastro.2022.06.052. Epub 2022 Jun 24.
9
Biomarkers of systemic treatment response in people with psoriasis: a scoping review.银屑病患者全身性治疗反应的生物标志物：范围综述。
Br J Dermatol. 2022 Oct;187(4):494-506. doi: 10.1111/bjd.21677. Epub 2022 Jul 20.
10
EULAR points to consider for therapeutic drug monitoring of biopharmaceuticals in inflammatory rheumatic and musculoskeletal diseases.欧洲抗风湿病联盟关于炎症性风湿和肌肉骨骼疾病生物制药治疗药物监测的考虑要点
Ann Rheum Dis. 2023 Jan;82(1):65-73. doi: 10.1136/annrheumdis-2022-222155. Epub 2022 May 12.